Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Korea first to approve Invossa-K cell and gene therapy for degenerative arthritis

July 13, 2017

Nektar Therapeutics describes activity of autoimmune disease candidate NKTR-358

July 12, 2017

FDA designates tadekinig alfa an orphan treatment for Still's disease

July 10, 2017

Sirukumab named orphan drug in the U.S. for juvenile idiopathic arthritis

July 10, 2017

Padlock Therapeutics patents protein-arginine deiminase type-4 inhibitors

July 7, 2017

FDA approves Bristol-Myers Squibb's Orencia in psoriatic arthritis

July 7, 2017

Innocare initiates phase I trial of ICP-022

July 6, 2017

Daiichi Sankyo discontinues Japanese development of etanercept biosimilar CHS-0214

July 5, 2017

Japan's MHLW approves Olumiant for rheumatoid arthritis

July 4, 2017

Pralia approved for additional indication in Japan

July 4, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...